You are viewing: India Latent TB Testing Market analysis
Part of: Latent TB Testing Market (Global)

The India Latent TB Testing Market was valued at $25.97 Million in 2024 and projected to reach to $42.42 Million by 2029, representing a compound annual growth rate of 10.3%. India's latent TB testing market is positioned for sustained growth through 2029, driven by escalating public health initiatives and improved diagnostic accessibility.

India Latent TB Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

India Latent TB Testing Market Trends and Insights

  • This expansion in India reflects increasing awareness of tuberculosis prevention, strengthened diagnostic infrastructure, and rising healthcare investments across the nation.
  • India's market growth significantly outpaces global trends, driven by the country's substantial TB burden and government initiatives to identify and treat latent infections before they progress to active disease. The latent TB testing market in India is supported by expanding access to advanced diagnostic technologies, including interferon-gamma release assays (IGRAs) and tuberculin skin tests (TSTs).
  • India's healthcare sector is increasingly prioritizing early detection and preventive treatment strategies, particularly among high-risk populations such as healthcare workers, immunocompromised individuals, and close contacts of TB patients.
  • Between 2024 and 2029, India is expected to see heightened adoption of latent TB testing across both public and private healthcare settings, driven by regulatory support and growing clinical recognition of the importance of latent TB management..

Key Market Statistics

  • CAGR (2024-2029) 10.3% CAGR
  • Market Size, 2024 ~USD 25.97 Million
  • Forecast, 2029 ~USD 42.42 Million
  • Country India

India Latent TB Testing Market Overview

Rapid Market Expansion :

India's latent TB testing market is growing at 10.3% CAGR, significantly outpacing the global growth rate of 5.8%, driven by increased government TB elimination initiatives and diagnostic infrastructure development.

Substantial Market Valuation :

The market is valued at $25.97 million in 2024 and is projected to reach $42.42 million by 2029, representing a 63.4% increase over five years, reflecting strong investment in TB prevention programs.

Rising Diagnostic Awareness :

Increasing awareness of tuberculosis prevention among Indian healthcare providers and patients is driving demand for latent TB testing, supported by strengthened diagnostic infrastructure across urban and semi-urban regions.

Government-Backed Growth :

India's commitment to TB elimination through the National TB Elimination Program and rising healthcare investments are creating favorable conditions for latent TB testing adoption and market penetration.

India Latent TB Testing Market Dynamics

  • The government's aggressive TB elimination agenda, combined with enhanced healthcare infrastructure investments, is creating robust demand for latent TB testing solutions across both public and private healthcare sectors. The market's 10.3% CAGR reflects India's strategic focus on early TB detection and prevention.
  • Rising healthcare expenditure, increasing awareness among medical professionals, and expanding diagnostic capabilities in tier-2 and tier-3 cities are expected to accelerate market adoption.
  • This growth trajectory positions India as a critical market for latent TB testing providers seeking expansion in high-burden TB regions..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • India's latent TB testing market is valued at $25.97 million in 2024 and is forecast to reach $42.42 million by 2029, growing at a 10.3% CAGR.
    • India's market growth rate of 10.3% significantly exceeds the global CAGR of 5.8%, reflecting the country's high TB prevalence and policy focus on latent TB detection.
    • India's healthcare infrastructure expansion and government TB elimination initiatives are driving increased adoption of diagnostic testing technologies across public and private sectors.
    • India's latent TB testing market is expected to benefit from rising awareness among healthcare workers and vulnerable populations, supporting preventive treatment strategies through 2029.

    Latent TB Testing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment HOUSEHOLD CONTACTS WITH PULMONARY TB (Application)
    Forecast Period 2024-2029
    Growth Rate CAGR of 5.8% from 2024 to 2029
    Largest Segment IGRA (Test Type)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.77 (2029)
    Segments Covered Test Type, Application, End User

    India Latent TB Testing Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Test Type

    • Igra
    • Tst

    By Application

    • Household Contacts With Pulmonary Tb
    • Other Applications
    • People Living With Hiv

    By End User

    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Other End Users

    INDIA: LATENT TB TESTING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES1.872.222.342.492.672.893.153.448
    DIAGNOSTIC LABORATORIES14.3717.4718.8420.4822.4924.8727.6930.9610.4
    HOSPITALS & CLINICS5.216.236.67.057.618.289.069.968.6
    OTHER END USERS1.191.41.471.541.641.761.892.056.9
    TOTAL22.6427.3229.2531.5734.4237.7941.7846.429.7

    Target Audience

    • Diagnostic Equipment Manufacturers : Need India-specific market data to develop product strategies, identify distribution partnerships, and capitalize on the 10.3% CAGR growth in latent TB testing demand across Indian healthcare facilities.
    • Healthcare Investment Firms : Require detailed India market insights to evaluate investment opportunities in TB diagnostics, assess market potential, and identify high-growth segments within India's expanding healthcare sector.
    • Government Health Agencies : Utilize market data to support TB elimination program planning, budget allocation, and infrastructure development initiatives aligned with India's national tuberculosis control objectives.
    • Clinical Laboratory Operators : Need India market forecasts to plan capacity expansion, invest in latent TB testing capabilities, and position services to meet growing demand from public health programs and private healthcare providers.
    • Healthcare Consultants and Advisors : Require India-specific market analysis to provide clients with actionable insights on TB testing market opportunities, competitive landscape, and strategic recommendations for market entry or expansion.

    Reasons to Buy this Report

    • Market-Specific Growth Intelligence : Gain detailed insights into India's 10.3% CAGR latent TB testing market, with precise valuation data and five-year forecasts essential for strategic planning and investment decisions in this high-growth region.
    • Competitive Positioning Strategy : Understand India's unique market dynamics, government TB elimination initiatives, and diagnostic infrastructure developments to identify competitive advantages and market entry opportunities ahead of competitors.
    • Investment and Expansion Planning : Access comprehensive market sizing ($25.97M to $42.42M projection) to support business case development, resource allocation, and expansion strategies tailored to India's healthcare landscape.
    • Stakeholder Alignment : Leverage India-specific market data to align internal teams, secure stakeholder buy-in, and justify investments in latent TB testing solutions targeting India's growing healthcare sector.
    • Risk Mitigation and Forecasting : Utilize India market forecasts and growth drivers to anticipate market trends, assess regulatory developments, and develop contingency strategies for sustainable market presence.

    Frequently asked questions

    What is the current size of India's latent TB testing market?

    India's latent TB testing market was valued at $25.97 million in 2024 and is projected to grow to $42.42 million by 2029.

    What is the growth rate of India's latent TB testing market?

    India's latent TB testing market is growing at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2029.

    What diagnostic technologies are driving India's latent TB testing market?

    India's market is driven by interferon-gamma release assays (IGRAs), tuberculin skin tests (TSTs), and other advanced diagnostic technologies that enable early detection of latent TB infections.

    Which populations are the primary focus for latent TB testing in India?

    India's latent TB testing initiatives primarily target healthcare workers, immunocompromised individuals, close contacts of TB patients, and other high-risk populations.

    How does India's latent TB testing market growth compare to global trends?

    India's market CAGR of 10.3% significantly outpaces the global CAGR of 5.8%, reflecting India's higher TB burden and stronger policy emphasis on latent TB detection and prevention.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the latent TB testing market. Exhaustive secondary research was done to collect information on the latent TB testing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the latent TB testing market.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    The following is a breakdown of the primary respondents:

    Note 1: Others include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    QIAGEN General Manager
    Revvity Area Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the latent TB testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the latent TB testing market have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Latent tuberculosis testing refers to diagnosing the infection by detecting an immune response to Mycobacterium tuberculosis antigens using either the tuberculin skin test (TST) or interferon-gamma release assays (IGRAs). These tests help identify dormant tuberculosis infections in individuals without active symptoms.

    Stakeholders

    • Senior Management
    • End User
    • Finance/Procurement Department  
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global latent TB testing market, by test type, application, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall latent TB testing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, and Latin America
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

     

    Get the Full Latent TB Testing Market Report

    Full forecast, segment splits, and company analysis for all Latent TB Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status